Poor survival outcomes in HER2 positive breast cancer patients with low grade, node negative tumours. Implications for trastuzumab therapy?

Tovey, S., Marla, S., Brown, S., Burton, P., Canney, P., Stallard, S., Mallon, E., Edwards, J. and Cooke, T. (2009) Poor survival outcomes in HER2 positive breast cancer patients with low grade, node negative tumours. Implications for trastuzumab therapy? Cancer Research, 69(2), S98-0. (doi: 10.1158/0008-5472.SABCS-702)

Full text not currently available from Enlighten.


Item Type:Articles
Additional Information:Abstract from the 31st Annual San Antonio Breast Cancer Symposium, San Antonio, TX, USA, 10-14 Dec 2008.
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Edwards, Professor Joanne
Authors: Tovey, S., Marla, S., Brown, S., Burton, P., Canney, P., Stallard, S., Mallon, E., Edwards, J., and Cooke, T.
Subjects:R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
College/School:College of Medical Veterinary and Life Sciences > Institute of Cancer Sciences
Journal Name:Cancer Research
ISSN:0008-5472
ISSN (Online):1538-7445

University Staff: Request a correction | Enlighten Editors: Update this record